Indofarma Tbk
PT Indofarma Tbk, together with its subsidiaries, manufactures and sells pharmaceutical products in Indonesia and internationally. The company offers laboratory, pharmaceutical, and health glass equipment; orthopedic and prosthetic equipment; medical and dental equipment; and reparation of Irradiation / X-ray, electromedical and electrotherapy equipment. It also trades in laboratory, pharmaceutic… Read more
Indofarma Tbk - Asset Resilience Ratio
Indofarma Tbk (INAF) has an Asset Resilience Ratio of 16.37% as of September 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2000–2022)
This chart shows how Indofarma Tbk's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Indofarma Tbk's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rp209.05 Billion | 14.02% |
| Short-term Investments | Rp35.00 Billion | 2.35% |
| Total Liquid Assets | Rp244.05 Billion | 16.37% |
Asset Resilience Insights
- Good Liquidity Position: Indofarma Tbk maintains a healthy 16.37% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Indofarma Tbk Industry Peers by Asset Resilience Ratio
Compare Indofarma Tbk's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF |
Drug Manufacturers - Specialty & Generic | -0.02% |
|
Kamada
NASDAQ:KMDA |
Drug Manufacturers - Specialty & Generic | 21.63% |
|
Dongwha Pharm.Co.Ltd
KO:000020 |
Drug Manufacturers - Specialty & Generic | 1.92% |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078 |
Drug Manufacturers - Specialty & Generic | 0.46% |
|
Yuhan Corp.
KO:000100 |
Drug Manufacturers - Specialty & Generic | 0.99% |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153 |
Drug Manufacturers - Specialty & Generic | 1.81% |
|
Kotra Industries Bhd
KLSE:0002 |
Drug Manufacturers - Specialty & Generic | 9.82% |
|
Yuyu Pharma Inc
KO:000227 |
Drug Manufacturers - Specialty & Generic | 1.74% |
Annual Asset Resilience Ratio for Indofarma Tbk (2000–2022)
The table below shows the annual Asset Resilience Ratio data for Indofarma Tbk.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2022-12-31 | 20.04% | Rp307.44 Billion | Rp1.53 Trillion | +1.29pp |
| 2021-12-31 | 18.76% | Rp377.34 Billion | Rp2.01 Trillion | +13.87pp |
| 2020-12-31 | 4.88% | Rp83.65 Billion | Rp1.71 Trillion | +5.86pp |
| 2019-12-31 | -0.98% | Rp-13.57 Billion | Rp1.38 Trillion | -0.03pp |
| 2018-12-31 | -0.95% | Rp-13.76 Billion | Rp1.44 Trillion | -0.04pp |
| 2017-12-31 | -0.91% | Rp-13.93 Billion | Rp1.53 Trillion | +0.11pp |
| 2016-12-31 | -1.02% | Rp-14.11 Billion | Rp1.38 Trillion | -0.09pp |
| 2015-12-31 | -0.93% | Rp-14.29 Billion | Rp1.53 Trillion | -0.93pp |
| 2011-12-31 | 0.00% | Rp28.00 Million | Rp1.11 Trillion | 0.00pp |
| 2010-12-31 | 0.00% | Rp30.50 Million | Rp733.96 Billion | +0.00pp |
| 2009-12-31 | 0.00% | Rp25.00 Million | Rp728.03 Billion | +0.00pp |
| 2008-12-31 | 0.00% | Rp25.00 Million | Rp965.81 Billion | -0.23pp |
| 2007-12-31 | 0.23% | Rp2.34 Billion | Rp1.01 Trillion | -0.99pp |
| 2006-12-31 | 1.22% | Rp8.39 Billion | Rp686.94 Billion | -0.72pp |
| 2005-12-31 | 1.94% | Rp10.08 Billion | Rp518.82 Billion | -5.71pp |
| 2004-12-31 | 7.65% | Rp40.08 Billion | Rp523.92 Billion | +3.17pp |
| 2003-12-31 | 4.48% | Rp28.50 Billion | Rp635.96 Billion | -0.51pp |
| 2002-12-31 | 4.99% | Rp40.44 Billion | Rp810.03 Billion | -1.40pp |
| 2001-12-31 | 6.39% | Rp51.89 Billion | Rp811.62 Billion | -3.24pp |
| 2000-12-31 | 9.63% | Rp51.85 Billion | Rp538.17 Billion | -- |